News

In addition to its injectable formulation, Jade Pharmaceutical (JPI) anticipates offering Goodnak in capsules and an easy-to-apply lotion. Based on general market information, the proposed pricing for these

Under terms of these agreements, Bayer will supply Barr with the generic products for launch prior to the expiration of the patents protecting these products and Barr will

Under a 2007 agreement between the two companies, Micromet and Nycomed develop MT203, a fully human anti-GM-CSF antibody that may be useful for the treatment of various inflammatory

The studies will be conducted by Charles River Laboratories, and follows a recently completed 28-day preclinical safety program, also performed by Charles River. AKP-020 is the product designation

The Aethlon Hemopurifier is a medical device created to provide real-time therapeutic filtration of infectious viruses and immunosuppressive proteins. According to the company, the Hemopurifier holds promise to

The company won the exclusive rights through an on-line bidding system called the “Guangdong Sunshine Medicine Public Internet Bidding System’. Among the 2,300 products that the Company has

The placement consists of 15.72 million units and four million prepaid warrant units. Each unit is comprised of one common share in the company and one share purchase

The Australian patent and divisional patent were recently sealed by IP Australia. A further two divisional applications have completed the examination process and have been accepted to grant.

In conjunction with this decision, the company also announced that it has terminated its supply agreement with Asubio Pharma and Nippon Soda for production of faropenem. These decisions